See What HealthDay Can Do For You
Contact Us

New Inflammatory Biomarker ID'd in Lumbar Disc Herniation

Cases with positive straight-leg raising test have elevated immunostaining rates for E-selectin

New Inflammatory Biomarker ID'd in Lumbar Disc Herniation

FRIDAY, Nov. 30 (HealthDay News) -- The leukocyte adhesion protein E-selectin is an inflammatory biomarker in the pathogenesis of lumbar disc herniation, according to a study published in the December issue of the Journal of Spinal Disorders & Techniques.

Kadir Tufan, M.D., of Baskent University in Ankara, Turkey, and colleagues conducted a study involving herniated disc specimens from 50 patients who had unilateral persistent radicular pain or unilateral radicular motor paresis to evaluate the prevalence of E-selectin with other inflammatory biomarkers, including CD20, CD45, and CD68. The authors assessed the relative risk of the straight-leg raising (SLR) test positivity or negativity in conjunction with CD20, CD45, CD68, and E-selectin staining.

The researchers found that immunostaining rates were higher with E-selectin and CD45 in cases with positive SLR. There was no significant association between positive SLR and CD20 or CD68.

"We suggest that E-selectin is as valuable as the other well-known inflammatory markers in the pathogenesis of lumbar disc herniation," the authors write. "In our opinion, other than well-known nonsteroidal anti-inflammatory drugs, antagonists targeting E-selectin can be potentially effective therapeutics for controlling inflammation in lumbar disc herniation."

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.